Related Experiment Video
Updated: May 13, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer
Ji Heon Noh1, Young Gyoon Chang, Min Gyu Kim
1Lab of Oncogenomics, Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Abstract:
Aberrant regulation of histone deacetylase 2 (HDAC2) plays a pivotal role in the development of hepatocellular carcinoma (HCC), but, the underlying mechanism leading to HDAC2 overexpression is not well understood. We performed microRNA (miRNA) profiling analysis in a subset of HCCs, and identified four down-regulated miRNAs that may target HDAC2 in HCC. Ectopic expression of miRNA mimics evidenced that miR-145 suppresses HDAC2 expression in HCC cells. This treatment repressed cancer cell growth and recapitulated HDAC2 knockdown effects on HCC cells. In conclusion, we suggest that loss or suppression of miR-145 may cause aberrant overexpression of HDAC2 and promote HCC tumorigenesis.
Insights
Loss of miR-145 in hepatocellular carcinoma (HCC) leads to increased histone deacetylase 2 (HDAC2) expression. Restoring miR-145 suppresses tumor growth, suggesting a novel therapeutic target for HCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant histone deacetylase 2 (HDAC2) regulation is implicated in hepatocellular carcinoma (HCC) development.
- The specific mechanisms driving HDAC2 overexpression in HCC remain unclear.
Purpose of the Study:
- To investigate the role of microRNAs (miRNAs) in regulating HDAC2 expression in HCC.
- To identify specific miRNAs that target HDAC2 and their functional impact on HCC progression.
Main Methods:
- miRNA profiling was conducted on a subset of HCC samples.
- Ectopic expression of miRNA mimics was used to assess the effect on HDAC2 levels in HCC cells.
- Functional assays were performed to evaluate the impact on cancer cell growth.
Main Results:
- Four downregulated miRNAs potentially targeting HDAC2 were identified in HCC.
- miR-145 was confirmed to suppress HDAC2 expression in HCC cells.
- Restoration of miR-145 inhibited HCC cell proliferation and mimicked the effects of HDAC2 knockdown.
Conclusions:
- Loss or suppression of miR-145 contributes to aberrant HDAC2 overexpression in HCC.
- miR-145 acts as a tumor suppressor by inhibiting HDAC2, presenting a potential therapeutic strategy for HCC.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
